EGFR and non-small cell lung carcinoma: In conclusion, this study demonstrates that radiomics-clinical model integrates multiregional features and clinical factors and is a non-invasive and efficient method for assessing the response of NSCLC patients to EGFR-TKIs and ICIs therapies.